JUL 17, 2018 01:17 PM PDT

Hunger Hormones for Addiction Treatment?

WRITTEN BY: Nouran Amin

Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment for drug and alcohol addiction.

After gut hormones have received attention from scientists seeking to understand ingestive behavior and obesity, researchers have discovered a relation between these particular hormones and addiction.

"Hormones from the gut act in the brain to modulate dopamine signaling, which controls decisions to seek out rewards," explained Dr. Mitchell Roitman from the University of Illinois-Chicago. This explains how food and water become more or less rewarding based on an individuals state of hunger, fullness, or thirst.

Addiction, for example, from cocaine and alcohol act on those same dopamine circuits in the brain, gut hormones could potentially turn their rewarding effects up or down in the same fashion.

Ghrelin, a hunger hormone released by the stomach, can exert its effects on the reward value of alcohol much like it increases the reward value of food, according to results shared by Dr. Lorenzo Leggio, leader of a joint team from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). Other gut hormones like GLP-1 and amylin, which are released during the process of ingestion, signal the brain when they had enough to eat.

The NIAAA/NIDA research team has shown that ghrelin promotes the alcohol-seeking behavior in individuals with alcohol use disorder. More recently, the research team studied rats that are genetically insensitive to ghrelin, an approach that further encourages the role of the ghrelin system in alcohol seeking.

"These results provide a strong rationale for clinical trials of GLP-1 analogs for people seeking addiction treatment," says Dr. Heath Schmidt of the University of Pennsylvania's Perelman Medical School. "Medications affecting GLP-1 and amylin are already FDA approved for Type II diabetes and obesity. These drugs could be re-purposed for treating drug craving and relapse."

Substance abuse disorders are currently one of the most prevalent and expensive chronic health problems. According to government statistics, in the United States, over 21 million adults need treatment for alcohol or illicit drug abuse. Behavioral therapy is the standard treatment approach, however, persistent cravings lead to an increase in relapse rates. Presently, only a few medications are approved to help manage cravings, but these medications do not hold high efficacy for all people.

Data from animal experiments and preliminary trials in humans continues to support the gut hormone system as the needed target for novel treatments.

Source: Society for the Study of Ingestive Behavior

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 18, 2019
Drug Discovery
SEP 18, 2019
Cholesterol Medication May Double Type 2 Diabetes Risk
A research study examining thousands of patient’s health records found an association between prescribed cholesterol-lowering statins and the risk of...
SEP 18, 2019
Drug Discovery
SEP 18, 2019
Does Microdosing Really Boost Productivity and Creativity?
Microdosing is the practice of ingesting very low doses of psychedelic substances, typically a twentieth of a recreational dose. In particular, Lysergic ac...
SEP 18, 2019
Drug Discovery
SEP 18, 2019
Can FDA Approved Ketamine Drug Spravato Really Treat Depression?
President Trump is allegedly in support of a new drug to combat depression. He even urged the Department of Veterans Affairs to purchase it and “get ...
SEP 18, 2019
Cardiology
SEP 18, 2019
Somethings Fishy With Omega 3 Claims
Each month nearly 20 million Americans turn to fish oil for heart disease prevention. Though it may sound healthy, this trend is troubling in the face of z...
SEP 18, 2019
Clinical & Molecular DX
SEP 18, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
SEP 18, 2019
Cell & Molecular Biology
SEP 18, 2019
How the Kava Plant Creates Medicinal Compounds
Nature has given us some of our best medicines; it's thought that as many as half the drugs we used are derived from natural products....
Loading Comments...